China Pharma Holdings Inc Net Asset Quality Index
China Pharma Holdings Inc net asset quality index. China Pharma Holdings Inc (CPHI) has a Net Asset Quality Index of 53.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $15.98 Million minus total liabilities of $7.49 Million yields net assets of $8.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is China Pharma Holdings Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of China Pharma Holdings Inc (2001–2024)
Net asset quality index of China Pharma Holdings Inc from 2001 to 2024. This chart shows how China Pharma Holdings Inc's Net Asset Quality Index has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the index stands at 53.1%, representing net assets of $8.49 Million against total assets of $15.98 Million USD. See shareholders equity of China Pharma Holdings Inc for net asset value and shareholders' equity analysis.
China Pharma Holdings Inc Net Asset Quality Index by Year (2001–2024)
China Pharma Holdings Inc net asset quality index by year from 2001 to 2024. The table below presents the year-by-year Net Asset Quality Index for China Pharma Holdings Inc from 2001 to 2024, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CPHI market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 52.0% | $7.75 Million | $14.89 Million | $7.14 Million | ▲ +6.8 pp |
| 2023 | 45.3% | $7.45 Million | $16.47 Million | $9.01 Million | ▲ +21.1 pp |
| 2022 | 24.1% | $4.29 Million | $17.78 Million | $13.49 Million | ▼ -2.4 pp |
| 2021 | 26.6% | $6.02 Million | $22.65 Million | $16.63 Million | ▼ -11.3 pp |
| 2020 | 37.9% | $8.00 Million | $21.12 Million | $13.11 Million | ▼ -3.6 pp |
| 2019 | 41.5% | $9.24 Million | $22.24 Million | $13.00 Million | ▼ -25.0 pp |
| 2018 | 66.6% | $30.20 Million | $45.38 Million | $15.18 Million | ▼ -5.3 pp |
| 2017 | 71.8% | $43.07 Million | $59.95 Million | $16.88 Million | ▼ -3.2 pp |
| 2016 | 75.0% | $58.91 Million | $78.52 Million | $19.61 Million | ▲ +0.3 pp |
| 2015 | 74.7% | $72.64 Million | $97.22 Million | $24.58 Million | ▼ -5.7 pp |
| 2014 | 80.4% | $106.25 Million | $132.08 Million | $25.83 Million | ▼ -3.9 pp |
| 2013 | 84.3% | $132.94 Million | $157.61 Million | $24.67 Million | ▼ -6.6 pp |
| 2012 | 91.0% | $148.52 Million | $163.24 Million | $14.72 Million | ▼ -0.1 pp |
| 2011 | 91.1% | $142.48 Million | $156.39 Million | $13.91 Million | ▲ +1.6 pp |
| 2010 | 89.5% | $117.94 Million | $131.75 Million | $13.81 Million | ▼ 0.0 pp |
| 2009 | 89.6% | $90.40 Million | $100.94 Million | $10.54 Million | ▼ -3.0 pp |
| 2008 | 92.6% | $69.87 Million | $75.47 Million | $5.60 Million | ▲ +1.6 pp |
| 2007 | 91.0% | $39.76 Million | $43.71 Million | $3.94 Million | ▲ +17.9 pp |
| 2006 | 73.1% | $20.85 Million | $28.51 Million | $7.66 Million | ▲ +81408.8 pp |
| 2005 | -81335.7% | $-68.32K | $84.00 | $68.41K | ▲ +0.0 pp |
| 2004 | -81335.7% | $-68.32K | $84.00 | $68.41K | ▼ -81089.9 pp |
| 2003 | -245.8% | $-733.96K | $298.63K | $1.03 Million | ▼ -112.7 pp |
| 2002 | -133.0% | $-566.35K | $425.67K | $992.02K | ▲ +0.0 pp |
| 2001 | -133.0% | $-566.35K | $425.67K | $992.02K | — |